Emollients in psoriasis therapy

Abstract

Objective. To study the efficacy of Blue Cap emollient in patients with psoriasis. Material and methods. The study included 10 patients with psoriasis vulgaris, limited form, stationary stage. Patients were divided into 2 groups: 1st (n=5) – patients received basic therapy (betamethasone + calcipotriol ointment once a day for 2 weeks) against the background of emollient application (containing piroctonolamine, bisabolol, ceramides, cholesterol, phytosphingosine, glycerol, glyceryl stearate); 2nd (n=5) - patients received only basic therapy. The severity of the course of psoriasis and the effectiveness of therapy according to clinical signs were assessed using the Psoriasis Area and Severity Index (PASI). The severity of pruritus and the impact of pruritus on patients' quality of life were assessed using the Behavioral rating scores (BRS) questionnaire and the pruritus index “Prurindex”. Results. Inclusion of Blue Cap emollient into the treatment protocol of psoriasis patients against the background of basic therapy (betamethasone + calcipotriol) promoted a significant decrease in PASI and improvement of skin condition in comparison with the group receiving only basic therapy.